Document Preview Unavailable
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes
Cavo Alessia; Rubagotti Alessandra; Zanardi, Elisa; Fabbroni Chiara; Zinoli Linda; et al. Therapeutic Advances in Medical Oncology Vol. 10, (Jan 2018).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library